UEG Week 2025: Microplastics found to change gut microbiome in first human-sample study
BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week…
EssilorLuxottica: Third-Quarter 2025 Revenue Conference Call Invitation
Third-Quarter 2025 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr…
ESD Alliance Reports Electronic System Design Industry Posts $5.1 Billion in Revenue in Q2 2025
Geographic Regions Americas and EMEA Reported Double-Digit Increases MILPITAS, Calif., Oct. 6,…
Aptos Experience 2025 Kicks Off in New York City on October 15-16
Two Days of Breakthrough Innovation, Bold Ideas, and Real-World Connections NEW YORK,…
2025 World Trade Centers Association Member Forum to Focus on Private Sector’s Role in Strengthening Global Business Ties
Under the theme 'Empowering Emerging Voices,' WTCA members will gather for a…
MIT Technology Review Reveals 2025 list of 10 Climate Tech Companies to Watch
The annual list highlights the world's most promising innovations tackling climate change…
Get ready for the “BIGGEST SURPRISE” of 2025 from Gravity
SOMETHING BIG IS COMING! BANGKOK, Oct. 6, 2025 /PRNewswire/ -- Calling all gamers…
Department of Culture and Tourism – Experience Abu Dhabi: Celebrities Spotted at NBA Abu Dhabi Games 2025
From Hollywood A-lister Adrien Brody to Bollywood superstar Ranveer Singh, here are…
Arvinas Presents Late Breaking, Positive Phase 1 Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinsons Disease and Movement Disorders
– ARV-102 was well tolerated in clinical trials for both healthy volunteers…
Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025
October 05, 2025 09:00 ET | Source: Spyre Therapeutics, Inc. WALTHAM, Mass.,…
